Die Philipps-Universität Marburg umfasst 16 Fachbereiche, deren Einrichtungen über das Marburger Stadtgebiet verteilt sind. Mit 26.355 Studenten zählt sie zu den mittelgroßen deutschen Volluniversitäten.

During the past decade, Philipps-Universität Marburg conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 5 clinical trials were completed, i.e. on average, 12.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philipps-Universität Marburg" #1 sponsor was "Philipps University Marburg Medical Center" with 19 trials, followed by "Acacia Pharma Ltd" with 4 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 4 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Philipps-Universität Marburg" #1 collaborator was "Philipps University Marburg Medical Center" with 7 trials as a collaborator, "German Research Foundation" with 3 trials as a collaborator, "Helmut Schmidt University" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "University Hospital, Essen" with 2 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Philipps-Universität Marburg" are "Parkinson's Disease" (3 trials), "Postoperative Nausea and Vomiting" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Antidepressants" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "Philipps-Universität Marburg" in a lesser frequency.

Most popular intervention types in "Philipps-Universität Marburg" are "Drug" (33 trials), "Behavioral" (15 trials), "Other" (15 trials), "Procedure" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "APD421" (3 trials), "Acceptance" (2 trials), "Heat pain" (2 trials) and "Placebo nasal spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "Philipps-Universität Marburg" are 60 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Philipps-Universität Marburg". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Philipps-Universität Marburg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Philipps-Universität Marburg, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 26 trials that are defined as “Not Applicable".

Philipps-Universität Marburg has several departments that took part in Clinical trials: "Department of Clinical Psychology and Psychotherapy, Philipps University Marburg" - 22 trials, "Department of Psychology, Philipps University Marburg" - 8 trials, "Neurologische Klinik der Philipps-Universität Marburg" - 4 trials, "University Marburg, Orthopedics and Rheumatology" - 2 trials, "Klinische Psychologie und Psychotherapie, Fachbereich Psychologie, Universität Marburg" - 2 trials, "Philipps-Universität Marburg, Hämatologie/Onkologie/Immunologie" - 2 trials, "Community based hemato-oncology medical office" - 2 trials